Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Articles by Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Targeted Treatment Options in Multiple MyelomaPublished: August 10th 2020 | Updated:
The Future of Multiple MyelomaPublished: August 10th 2020 | Updated:
A Look at the ENDURANCE TrialPublished: August 10th 2020 | Updated:
Maintenance Therapy in Multiple MyelomaPublished: August 10th 2020 | Updated:
Treatment Options in Relapsed/Refractory Multiple MyelomaPublished: August 10th 2020 | Updated:
Trials in Relapsed/Refractory Multiple MyelomaPublished: August 10th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5